Transgender care for minors gets first Supreme Court review: What to know

The Supreme Court will soon hear arguments in a landmark case that could set a pivotal precedent on states’ authority to regulate transgender hormone therapy procedures for minors.

At the heart of the set for oral arguments Wednesday is whether Tennessee’s Senate Bill 1 (SB1), a law barring puberty blockers, cross-sex hormones, and surgeries for minors, violates the Equal Protection Clause of the 14th Amendment.

While Republican lawmakers, including incoming President-elect Donald Trump, have sounded alarms about matters of fairness surrounding biological men competing on female sports teams, a larger underbelly of concern is brewing over the more than 14,000 minors who have undergone transgender-related procedures since 2019.

Read more on the Washington Examiner.

Protect Patients. Defend Medical Ethics.

Power our legal, policy, and research work to keep identity politics out of healthcare..